Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< RESEARCH IN PSYCHIATRY

February 2024

PSYCHIATRY

NOVEL PATHWAY EXPLAINS THE ESCALATION OF FEAR RESPONSES

Featuring: Jones Parker, PhD

Scientists have discovered a new neural pathway involved in how the brain encodes the transition to high-intensity fear response behaviors that are necessary for survival, according to a recent study published in Nature.

Jones Parker, PhD, assistant professor of Neuroscience, of Pharmacology and of Psychiatry and Behavioral Sciences, was a co-author of the study.

In mammals, the amygdala is involved in generating survival responses and transitioning to different high-intensity fear behaviors such as freezing or immobility (avoidance behavior) to escaping (flight behavior) in response to perceived threats.

When these responses are dysregulated in humans, however, they can cause psychiatric illnesses such as post-traumatic stress disorder or anxiety and panic disorders. Until now, the precise source of the neural circuits involved in these responses had remained poorly understood.

​In the current study, the investigators used mouse models developed by the laboratory of Jonathan Fadok, PhD, the Burk-Kleinpeter Inc. Professor in Science and Engineering at Tulane University and senior author of the study, to identify the neural circuits involved in the escalation of behavioral responses to high-intensity fearful situations.

Using a combination of techniques developed by Parker’s lab, including in vivo calcium imaging, the scientists discovered a previously unknown connection between the brain’s prefrontal cortex and the amygdala, which are involved in emotional regulation and adaptive decision-making, that controls and regulates this transition to high-intensity fear behaviors.
neurons
DP-to-CeA neurons exert excitatory control over CeM projections. Representative image shows expression of eYFP (green) and mCherry (red) in the CeM. Courtesy of Jonathan Fadok, PhD.

​The scientists then used chemogenetic and optogenetic techniques to manipulate this novel pathway in the mice and discovered a new neuronal projection involving neurotransmitter release from excitatory neurons in dorsal peduncular region of the prefrontal cortex, an understudied area of the brain, to neurons in the amygdala.

“We have the cortex, which is projecting to this ancient brain structure involved in fear processing, that taps into the amygdala and directly scales the level of fear that the animals are experiencing,” Parker said.

Furthermore, molecularly characterizing such regions of the brain involved in this escalation of fear responses may help identify novel therapeutic targets for different psychiatric illnesses, Parker added.

​“This links the prefrontal cortex — this area that expanded over evolution in humans, an area involved in expectations and predictions about our environment — to the ancient brain circuit that controls fear, so this could contribute to pathologies involving fear and how we conceptualize them” Parker said.

As for next steps, Fadok said his lab is currently performing a physiological analysis of the dorsal peduncular region of the prefrontal cortex to better characterize its neuronal population and overall function.

“By understanding what we call top-down control, so cortical control over these ancient structures that regulate fear, I think we can make major inroads to developing better treatments,” Fadok said.

This work was supported by the Louisiana Board of Regents through the Board of Regents support fund, National Institute of Mental Health grants R01MH122561 and R01MH119283, and National Institute of Neurological Disorders and Stroke grant R01NS122840.
​
This article was originally published in the Northwestern University Feinberg School of Medicine  on February 22,  2024.
Jones Parker, PhD headshot
Jones Parker, PhD, ​ assistant professor of Neuroscience, of Pharmacology and of Psychiatry and Behavioral Sciences, was a co-author of the study published in Nature.
​

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​
Call 844.344.6663
Find an NM Psychiatrist

You May Also Like

Brandon Hamm, MD video still

January 2024

PSYCHIATRY
Northwestern Medicine Ketamine Infusion Clinic
Michael Brook, PhD, video still

November 2023

PSYCHIATRY
Northwestern Medicine Forensic Psychiatry in Legal Proceedings and Public Health Solutions
Andrew C. New, MD video still

August 2023

PSYCHIATRY
Northwestern Medicine Behavioral Health Team Integration in the Emergency Department

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties